ATLANTTIC
Centro de investigación
Diana E.
Ayala García
Publicacións nas que colabora con Diana E. Ayala García (233)
2021
-
Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961
2020
-
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
European heart journal, Vol. 41, Núm. 48, pp. 4565-4576
2019
-
Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk
European Heart Journal
-
Diagnosis and management of hypertension: around-the-clock ambulatory blood pressure monitoring is substantially more effective and less costly than daytime office blood pressure measurements
Chronobiology International, Vol. 36, Núm. 11, pp. 1515-1527
2018
-
Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention
European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171
-
Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk
European Journal of Clinical Investigation, Vol. 48, Núm. 5
-
Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications article
Hypertension Research, Vol. 41, Núm. 5, pp. 342-353
2017
-
Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management
Heart Failure Clinics, Vol. 13, Núm. 4, pp. 759-773
-
Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy
Heart Failure Clinics, Vol. 13, Núm. 4, pp. 775-792
-
Sleep-time ambulatory BP is an independent prognostic marker of CKD
Journal of the American Society of Nephrology, Vol. 28, Núm. 9, pp. 2802-2811
-
Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention
Sleep medicine reviews, Vol. 33, pp. 17-27
2016
-
Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial
Diabetologia, Vol. 59, Núm. 2, pp. 255-265
-
Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks
Hypertension Research, Vol. 39, Núm. 5, pp. 277-292
-
Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention
Diabetologia
-
Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial [Diabetologia, DOI: 10.1007/s00125-015-3749-7]
Diabetologia
-
Presión arterial ambulatoria, cronoterapia de la hipertensión y glaucoma
Medicina Clinica, Vol. 146, Núm. 1, pp. 30-34
-
Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention
Diabetologia, Vol. 59, Núm. 2, pp. 244-254
2015
-
Ambulatory Blood Pressure Monitoring (ABPM) as THE reference standard to confirm diagnosis of hypertension in adults: Recommendation of the 2015 U.S. Preventive Services Task Force (USPSTF)
Chronobiology International
-
Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults
Chronobiology International, Vol. 32, Núm. 10, pp. 1329-1342
-
Bedtime hypertension chronotherapy: Concepts and patient outcomes
Current Pharmaceutical Design, Vol. 21, Núm. 6, pp. 773-790